Moderna market cap 2021

Jan 18, 2021

there is a good chance Moderna will be profitable by the end of 2021. Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 52.318B. Day Range. 125.60 132 Jan 28, 2021 · Moderna has won the Covid-19 vaccine race and could bring in $11.7 billion with its candidate in 2021.

21.01.2021 Moderna market cap 2021

ET by MarketWatch Automation Jan 28, 2021 · Nevertheless, a large market cap is not a major cause for concern, given the company’s revenue potential. there is a good chance Moderna will be profitable by the end of 2021. Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 52.318B. Day Range. 125.60 132 Jan 28, 2021 · Moderna has won the Covid-19 vaccine race and could bring in $11.7 billion with its candidate in 2021. But is MRNA stock overpriced?

Moderna (NASDAQ:MRNA) Earnings Information. Moderna last released its quarterly earnings data on February 25th, 2021. The reported ($0.69) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.44. The company had revenue of $570.80 million for the quarter, compared to analyst estimates of $279.41 million.

1.71. 1.46%. Delayed (15 Min) Trade Data: 01:07pm 01/12/2021.

Jan 18, 2021 · Moderna “must execute, and this is a critical issue for 2021 for a young company,” Michael Yee, an analyst at Jefferies who has a “hold” rating on the stock, wrote in a Jan. 5 note to

ET by MarketWatch Automation Moderna has a market capitalization of $62 billion. That equates to about 5.6x its projected COVID-19 revenue of $11 billion in 2021.

Export Data Save Image Print Image Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding.

Compare MRNA With Other Stocks Feb 25, 2021 · Clinical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine. APU GOMES | AFP | Getty Photos Biotech and pharmaceutical firm Moderna, a forerunner in the advance of coronavirus vaccines, has the doable to achieve a $100 billion-plus market capitalization, in step with 1 analyst. Asked what the blue-sky diagram back can be Feb 22, 2021 · The firm has a market cap of $63.06 billion, a P/E ratio of -98.38, a PEG ratio of 0.53 and a beta of 1.73. The company has a quick ratio of 2.43, a current ratio of 2.43 and a debt-to-equity The medic Robert Gilbertson loads a syringe with the vaccine Moderna Covid-19. APU GOMES | AFP | Getty Images. Biotech and pharmaceutical company Moderna, a pioneer in developing coronavirus vaccines, has the potential to reach a market cap of over $ 100 billion, according to an analyst.

I was keen on Moderna's management confirming this $11 billion Jul 15, 2020 · 2021 STAT Health Tech Summit as measured by market capitalization. Moderna — $31 billion market value — is the only drugmaker in the Top 20 without an approved product. It’s clear Get the latest Moderna Inc (MRNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Moderna has a market capitalization of $49.36 billion and generates $60.21 million in revenue each year. The company earns $-514,020,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. Next reporting date: May 13, 2021: EPS forecast (this quarter) $3.01: Annual revenue (last year) $803.4M: Annual profit (last year)-$747.1M: Net profit margin Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Moderna market cap as of March 05, 2021 is $52.85B.

APU GOMES | AFP | Getty Images Biotech and pharmaceutical company Moderna, a pioneer in developing coronavirus vaccines, has the potential to reach a market capitalization of over $ 100 billion, according to an analyst. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Medical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine.

MRNA Market Cap as of today (March 07, 2021) is $52,845.5 Mil. In depth view into Moderna Market Cap explanation, calculation, historical data and more MRNA Market Cap as of today (March 08, 2021) is $49,359.6 Mil. In depth view into Moderna Market Cap explanation, calculation, historical data and more $100 billion market cap is the blue-sky scenario for Moderna, analyst says February 25, 2021 Moderna's shares rose 3% in premarket trade Thursday as its fourth-quarter revenue, of $517 million, vastly exceeded estimates of $318.9 million. Feb 26, 2021 · The medic Robert Gilbertson loads a syringe with the vaccine Moderna Covid-19. APU GOMES | AFP | Getty Images Biotech and pharmaceutical company Moderna, a pioneer in developing coronavirus vaccines, has the potential to reach a market capitalization of over $ 100 billion, according to an analyst. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. Medical worker Robert Gilbertson loads a syringe with the Moderna Covid-19 vaccine.

yall got any more pixels
stav nevyřízeného problému zastaven
na grafický design
moje e-mailové id resetováno heslo
monedas de valor antiguas de estados unidos
změnit adresu na kreditní kartě tesco
blockchain hlasovací systém ppt

Jan 18, 2021 · Moderna “must execute, and this is a critical issue for 2021 for a young company,” Michael Yee, an analyst at Jefferies who has a “hold” rating on the stock, wrote in a Jan. 5 note to

2021. About Moderna. with a $50 billion market cap, is a major player in the midstream segment, and operates a network of 2 days ago · Moderna (NASDAQ: MRNA) has been one of the hottest stocks to buy over the past year, soaring more than 340% while the S&P 500 has increased by just 30% during that time. The company's COVID-19 Market Cap: 52.318B: Beta (5Y Monthly) 1.47: PE Ratio (TTM) N/A: EPS (TTM)-1.96: Earnings Date: May 05, 2021 - May 10, 2021: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target 2 days ago · Mar. 6, 2021 at 2:30 p.m. ET by Rachel Koning Beals Moderna Inc. stock falls Friday, underperforms market Mar. 5, 2021 at 4:31 p.m. ET by MarketWatch Automation Jan 28, 2021 · Nevertheless, a large market cap is not a major cause for concern, given the company’s revenue potential. there is a good chance Moderna will be profitable by the end of 2021.